Widwin Investment
Overview
Widwin Investment is a South Korean private equity and venture capital firm based in Seoul that invests in growth-stage companies through buyouts and also engages in venture capital investments in seed, early, and later-stage companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SM Lab | Dec 2021 | Series C | Co-investor |
| Medical AI Co., Ltd. | - | Growth Equity | Co-investor |
| NEWRACOM, Inc. | May 2026 | Series B | Co-investor |
| ProAbTech Co., Ltd. | Aug 2020 | Series A | Co-investor |
| SML Genetree | Nov 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Widwin Investment based?
Widwin Investment is headquartered in Seoul, South Korea.
When was Widwin Investment founded?
Widwin Investment was founded in 2008.
How many portfolio companies does Widwin Investment have?
Widwin Investment has 5 portfolio companies in Caplight's dataset.
What are some companies in Widwin Investment's portfolio?
Portfolio companies visible on Caplight include SM Lab, Medical AI Co., Ltd., NEWRACOM, Inc., ProAbTech Co., Ltd., SML Genetree.
What was Widwin Investment's most recent investment shown here?
Widwin Investment's most recent investment in this portfolio sample was in NEWRACOM, Inc. in 2026.
What sectors does Widwin Investment focus on?
Widwin Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Telecommunications & Networking, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Widwin Investment focus on?
Widwin Investment typically invests at the Early stage.